Skip to main content
padlock icon - secure page this page is secure

Inhibition of Respiration in Yeast by 2-Phenylethylamine

Buy Article:

$68.00 + tax (Refund Policy)

Background: 2-phenylethylamine (2-PEA) is an organic neurotransmitter which belongs to a class of biogenic amines that are essential for regulation of cellular development, differentiation and homeostasis. This class of compounds have been reported to cause oxidative stress to neuronal cells in the brain, which have a high oxygen consumption rate, elevated iron content and low antioxidant concentration. 2-phenylethylamine can metabolise into hydroxyl radicals which have been found to be a direct cause of oxidative stress within cells.

Methods: This study has examined the toxicity of 2-phenylethylamine in the yeasts, Saccharomyces cerevisiae and Candida glabrata by examining growth with glucose or ethanol as sources, in the presence of 2-phenylethylamine.

Results: 2-phenylethylamine was found to be inhibitory to all strains of yeast where respiratory function was necessary, while growth where glucose was the carbon source was unaffected. Almost all growth inhibition could be reversed by antioxidants ascorbate and glutathione, indicating oxidative stress was the likely cause of toxicity through 2-PEA or one of its metabolites.

Conclusion: Yeast studies show that the biogenic amine, 2-phenylethylamine, targets respiratory function and that the inhibition can be reversed alleviated by the addition of glutathione or ascorbate.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: 2-phenylethylamine; ascorbic acid; glutathione; mitochondrial respiratory function; reactive oxygen; yeast

Document Type: Research Article

Publication date: March 1, 2018

More about this publication?
  • The journal aims to provide updates to researchers about new bioactive compounds with proven activities in various biological screenings and pharmacological models. The journal will contain information about the structures, biological activities and sources of chemical entities discovered or designed by researchers and published in leading journals. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia.

    The journal should prove to be essential reading for pharmacologists, pharmaceutical chemists and medicinal chemists who wish to be kept informed and up-to-date with the latest and most important developments about new bioactive compounds of natural or synthetic origin, including recent patents.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more